NRx Pharmaceuticals (NASDAQ: NRXP), a biopharmaceutical company focused on neuroplastic therapies for depression and PTSD, announced the formation of NRx Defense Systems Inc., a Florida-based research and development subsidiary dedicated to advancing combined neuroplastic treatments using D-cycloserine and transcranial magnetic stimulation supported by robotic-enabled neuronavigation. The subsidiary will be led by Dr. Dennis McBride, with […]

HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care innovation, announced it is commencing an underwritten public offering of shares of its common stock or common stock equivalents, with all securities to be offered by the company and the final size and terms subject to market conditions. The company said it intends to […]

Beeline Holdings (NASDAQ: BLNE) announced a strategic partnership with Structured Real Estate Group to integrate its Embedded Mortgage and Title solutions into SRG’s AI-driven real estate platform, enabling homebuyers to access personalized financing, evaluate total ownership costs and initiate the mortgage process within a single digital environment. The collaboration will support the development of approximately […]

Independent research coverage can play a meaningful role in shaping how emerging biotechnology companies are evaluated, particularly when it brings together clinical progress, financial positioning and forward-looking milestones into a cohesive outlook. A recent analysis from Zacks Small-Cap Research provides that perspective for Soligenix (NASDAQ: SNGX), offering a detailed review of the company’s pipeline, upcoming catalysts and valuation […]

Soligenix (NASDAQ: SNGX) was featured in a recent article that discussed its positioning in a landscape where modern biopharmaceutical innovation often revolves around a powerful idea: One scientific mechanism can unlock treatments for multiple diseases. “Soligenix exemplifies this strategy through its use of synthetic hypericin across two distinct dermatologic indications, illustrating how platform science can streamline […]

Next-generation system advances real-time drone threat detection and battlefield intelligence capabilities  Safe Pro Group (NASDAQ: SPAI) has commenced the commercial rollout of its NODE-X, a next-generation miniaturized AI-powered edge compute processor designed to analyze drone footage for threat detection in military maneuver support missions, following a recent government contract. The system is scheduled to participate in additional U.S. Army exercises through the second […]

Forward Industries (NASDAQ: FWDI) has appointed Mark Brazier as chief financial officer, effective April 13, 2026, succeeding Kathleen Weisberg, who will remain with the company as director of financial reporting. Brazier brings extensive experience in digital assets and institutional finance, most recently serving as CFO and head of regulatory at XBTO Global, and will oversee financial […]

Datavault AI (NASDAQ: DVLT) has entered a consulting partnership with AgSensor Solutions to identify, value and tokenize high-value agricultural data assets, targeting sectors such as soil sensing, sustainability data and agricultural IoT. The agreement leverages AgSensor’s industry expertise alongside Datavault AI’s Information Data Exchange (R), DataScore (R) and DataValue (R) platforms to create tokenized assets […]

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising. Trilogy Metals (NYSE American: TMQ) (TSX: TMQ) is entering a critical phase in its evolution, with President and CEO Tony Giardini listing out a couple of near-term catalysts that could significantly progress the company’s flagship assets in Alaska’s Ambler Mining District. […]

Beyond Meat (NASDAQ: BYND) has fallen from a peak valuation of more than $14 billion to penny stock territory, driven by a combination of declining sales, mounting losses, intensifying competition and eroding consumer demand, according to a MarketWatch report by Bill Peters and Tomi Kilgore. Once buoyed by IPO enthusiasm and expectations of mass adoption, the company now faces a shrinking addressable […]

Xeriant (OTCQB: XERI), a company focused on developing and commercializing advanced technologies, announced the completion of a critical phase of internal testing for its NEXBOARD(TM) composite building panel, demonstrating strong fire-resistant performance ahead of third-party certification. The company is preparing for formal NFPA 286 and ASTM E84 testing, following internal trials showing no combustion or smoke under extreme heat, […]

NRx Pharmaceuticals (NASDAQ: NRXP), a biopharmaceutical company focused on neuroplastic therapies for depression, PTSD and related conditions, announced the appointment of Glenn Tyson as its first Chief Commercial Officer as the company prepares for anticipated approval of its Abbreviated New Drug Application for a preservative-free ketamine product. Tyson brings more than 25 years of commercialization and sales experience, […]